Paxlovid Pfizer
-
U.S. FDA orders Pfizer to test 2nd Paxlovid course for rebound COVID patientsThe U.S. FDA has ordered Pfizer Inc PFE.N to test the effects of an additional course of its antiviral Paxlovid among people who experience a rebound in COVID-19 after treatmentHealthAug 19, 2022
-
Paxlovid oral treatment fails to prevent COVID-19 in household members: PfizerPfizer said a large trial found that its Paxlovid treatment was not effective at preventing infection in people living with someone who had been exposed to the virus.HealthApr 29, 2022
-
Paxlovid, Pfizer’s oral COVID-19 pill, approved in CanadaPfizer began a rolling submission with Health Canada in December for Paxlovid, which it said is designed to block a key enzyme needed for the COVID-19 virus to multiply.HealthJan 17, 2022
![]()
